Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Nestin as a novel therapeutic target for pancreatic cancer via tumor angiogenesis.

Yamahatsu K, Matsuda Y, Ishiwata T, Uchida E, Naito Z.

Int J Oncol. 2012 May;40(5):1345-57. doi: 10.3892/ijo.2012.1333.

PMID:
22246533
2.

Nestin+ cells and healing the infarcted heart.

Calderone A.

Am J Physiol Heart Circ Physiol. 2012 Jan 1;302(1):H1-9. doi: 10.1152/ajpheart.00716.2011. Review.

3.

Angiogenesis: a prognostic determinant in pancreatic cancer?

van der Zee JA, van Eijck CH, Hop WC, van Dekken H, Dicheva BM, Seynhaeve AL, Koning GA, Eggermont AM, ten Hagen TL.

Eur J Cancer. 2011 Nov;47(17):2576-84. doi: 10.1016/j.ejca.2011.08.016.

PMID:
21958461
4.

Anti-angiogenic agents in pancreatic cancer: a review.

Assifi MM, Hines OJ.

Anticancer Agents Med Chem. 2011 Jun;11(5):464-9. Review.

PMID:
21521158
5.

Nestin as a regulator of Cdk5 in differentiating myoblasts.

Pallari HM, Lindqvist J, Torvaldson E, Ferraris SE, He T, Sahlgren C, Eriksson JE.

Mol Biol Cell. 2011 May;22(9):1539-49. doi: 10.1091/mbc.E10-07-0568.

6.

Nestin in gastrointestinal and other cancers: effects on cells and tumor angiogenesis.

Ishiwata T, Matsuda Y, Naito Z.

World J Gastroenterol. 2011 Jan 28;17(4):409-18. doi: 10.3748/wjg.v17.i4.409. Review.

7.

Nestin is a novel target for suppressing pancreatic cancer cell migration, invasion and metastasis.

Matsuda Y, Naito Z, Kawahara K, Nakazawa N, Korc M, Ishiwata T.

Cancer Biol Ther. 2011 Mar 1;11(5):512-23.

8.

Nestin-driven green fluorescent protein as an imaging marker for nascent blood vessels in mouse models of cancer.

Hoffman RM.

Methods Mol Biol. 2011;689:183-204. doi: 10.1007/978-1-60761-950-5_11.

PMID:
21153793
9.

Determining the relationship between "microvessel density" and different grades of astrocytoma based on immunohistochemistry for "factor VIII-related antigen" (von Willebrand factor) expression in tumor microvessels.

Mahzouni P, Mohammadizadeh F, Mougouei K, Moghaddam NA, Chehrei A, Mesbah A.

Indian J Pathol Microbiol. 2010 Oct-Dec;53(4):605-10. doi: 10.4103/0377-4929.71996.

10.

Glioma stem/progenitor cells contribute to neovascularization via transdifferentiation.

Dong J, Zhao Y, Huang Q, Fei X, Diao Y, Shen Y, Xiao H, Zhang T, Lan Q, Gu X.

Stem Cell Rev. 2011 Mar;7(1):141-52. doi: 10.1007/s12015-010-9169-7.

PMID:
20697979
11.

On the origin and growth of gliomas.

Schiffer D, Annovazzi L, Caldera V, Mellai M.

Anticancer Res. 2010 Jun;30(6):1977-98. Review.

PMID:
20651342
12.

High expression levels of putative hepatic stem/progenitor cell biomarkers related to tumour angiogenesis and poor prognosis of hepatocellular carcinoma.

Yang XR, Xu Y, Yu B, Zhou J, Qiu SJ, Shi GM, Zhang BH, Wu WZ, Shi YH, Wu B, Yang GH, Ji Y, Fan J.

Gut. 2010 Jul;59(7):953-62. doi: 10.1136/gut.2008.176271.

PMID:
20442200
13.

The neural stem/progenitor cell marker nestin is expressed in proliferative endothelial cells, but not in mature vasculature.

Suzuki S, Namiki J, Shibata S, Mastuzaki Y, Okano H.

J Histochem Cytochem. 2010 Aug;58(8):721-30. doi: 10.1369/jhc.2010.955609.

14.

Nestin-expressing interfollicular blood vessel network contributes to skin transplant survival and wound healing.

Aki R, Amoh Y, Li L, Katsuoka K, Hoffman RM.

J Cell Biochem. 2010 May;110(1):80-6. doi: 10.1002/jcb.22512.

PMID:
20225276
15.

The molecular basis of vascular lumen formation in the developing mouse aorta.

Strilić B, Kucera T, Eglinger J, Hughes MR, McNagny KM, Tsukita S, Dejana E, Ferrara N, Lammert E.

Dev Cell. 2009 Oct;17(4):505-15. doi: 10.1016/j.devcel.2009.08.011.

16.

Overexpression of EphA2, MMP-9, and MVD-CD34 in hepatocellular carcinoma: Implications for tumor progression and prognosis.

Yang P, Yuan W, He J, Wang J, Yu L, Jin X, Hu Y, Liao M, Chen Z, Zhang Y.

Hepatol Res. 2009 Dec;39(12):1169-77. doi: 10.1111/j.1872-034X.2009.00563.x.

PMID:
19788698
17.

Peritumoral lymphatic microvessel density associated with tumor progression and poor prognosis in gastric carcinoma.

Coşkun U, Akyürek N, Dursun A, Yamaç D.

J Surg Res. 2010 Nov;164(1):110-5. doi: 10.1016/j.jss.2009.03.081.

PMID:
19628230
18.

Proliferation of immature tumor vessels is a novel marker of clinical progression in prostate cancer.

Gravdal K, Halvorsen OJ, Haukaas SA, Akslen LA.

Cancer Res. 2009 Jun 1;69(11):4708-15. doi: 10.1158/0008-5472.CAN-08-4417. Erratum in: Cancer Res. 2009 Jul 15;69(14):6005.

19.

Analysis of VEGF, Flt-1, Flk-1, nestin and MMP-9 in relation to astrocytoma pathogenesis and progression.

Hlobilkova A, Ehrmann J, Knizetova P, Krejci V, Kalita O, Kolar Z.

Neoplasma. 2009;56(4):284-90.

PMID:
19473053
Items per page

Supplemental Content

Support Center